Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth

被引:42
作者
Bhonde, MR
Hanski, ML
Notter, M
Gillissen, BF
Daniel, PT
Zeitz, M
Hanski, C
机构
[1] Charite Univ Med Berlin, Dept Gastroenterol, D-12200 Berlin, Germany
[2] Charite Univ Med Berlin, Dept Hematol, Berlin, Germany
[3] Charite, Dept Clin & Mol Oncol, Berlin, Germany
关键词
colon carcinoma; chemotherapy; irinotecan; apoptosis; cell cycle arrest;
D O I
10.1038/sj.onc.1209017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge of the type of biological reaction to chemotherapy is a prerequisite for its rational enhancement. We previously showed that irinotecan-induced DNA damage triggers in the HCT116p53(wt) colon carcinoma cell line a long-term cell cycle arrest and in HCT116p53(-/-) cells apoptosis (Magrini et al., 2002). To compare the contribution of long-term cell cycle arrest and that of apoptosis to inhibition of cell proliferation after irinotecan-induced DNA damage, we used this isogenic system as well as the cell lines LS174T (p53(wt)) and HT-29 (p53(mut)). Both p53wt cell lines responded to damage by undergoing a long-term tetraploid G1 arrest, whereas the p53mut cell lines underwent apoptosis. Cell cycle arrest as well as apoptosis caused a similar delay in cell proliferation. Irinotecan treatment also induced in mouse tumours derived from the p53wt cell lines a tetraploid G1 arrest and in those derived from the p53-deficient cell lines a transient G2/M arrest and apoptosis. The delay of tumour growth was in the same range in both groups, that is, arrest-and apoptosis-mediated tumour growth inhibition was comparable. In conclusion, cell cycle arrest as well as apoptosis may be equipotent mechanisms mediating the chemotherapeutic effects of irinotecan.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 53 条
[1]   Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line [J].
Abal, M ;
Bras-Goncalves, R ;
Judde, JG ;
Fsihi, H ;
de Cremoux, P ;
Louvard, D ;
Magdelenat, H ;
Robine, S ;
Poupon, MF .
ONCOGENE, 2004, 23 (09) :1737-1744
[2]  
Andreassen PR, 2001, CANCER RES, V61, P7660
[3]   Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1 [J].
Andreassen, PR ;
Lohez, OD ;
Lacroix, FB ;
Margolis, RL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1315-1328
[4]   Accumulation of mutant p53V143A modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status [J].
Bartussek, C ;
Naumann, U ;
Weller, M .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) :432-439
[5]   The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-xL protein [J].
Bhonde, MR ;
Hanski, ML ;
Magrini, R ;
Moorthy, D ;
Müller, A ;
Sausville, EA ;
Kohno, K ;
Wiegand, P ;
Daniel, PT ;
Zeitz, M ;
Hanski, C .
ONCOGENE, 2005, 24 (01) :148-156
[6]   Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan [J].
Boyer, J ;
McLean, EG ;
Aroori, S ;
Wilson, P ;
McCulla, A ;
Carey, PD ;
Longley, DB ;
Johnston, PG .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :2158-2167
[7]  
Brown JM, 1999, CANCER RES, V59, P1391
[8]   Opinion - The role of apoptosis in cancer development and treatment response [J].
Brown, JM ;
Attardi, LD .
NATURE REVIEWS CANCER, 2005, 5 (03) :231-237
[9]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[10]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501